Boothbay Fund Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Boothbay Fund Management's PFE Position: Q1 2026 in Review
Boothbay Fund Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 12,127 shares — an estimated $302K sold.
Boothbay Fund Management first reported a position in PFE in Q4 2014 and held it in 18 quarters. The position peaked at $72.4M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Boothbay Fund Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Boothbay Fund Management sold 12,127 Pfizer shares in Q1 2026, an estimated $302K.
- Boothbay Fund Management first reported a position in Pfizer in Q4 2014 and held it in 18 quarters.
- Boothbay Fund Management's Pfizer position peaked at $72.4M in Q4 2021.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.